Evidence map›Paper›PMID 40550914›Full record

ReviewCurrent cardiology reports2025

Innovating the Gold Standard: The Emerging Role of Echocardiographic Stress Testing in the Classification, Stratification, and Prognostication in Pulmonary Vascular Disease.

Garrett Goldin, Hoda Mombeini, Valentina Mercurio, Steven Hsu, Matthew R Lammi, Stephen C Mathai, Luna Gargani, Monica Mukherjee

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Garrett GoldinJohns Hopkins University Division of Cardiology, 301 Mason Lord Drive, Suite 2400, Baltimore, 21224m, MD, USA.
Hoda MombeiniJohns Hopkins University Division of Cardiology, 301 Mason Lord Drive, Suite 2400, Baltimore, 21224m, MD, USA.
Valentina MercurioDepartment of Translational Medical Sciences, Federico II University of Naples, Naples, Italy.
Steven HsuJohns Hopkins University Division of Cardiology, 301 Mason Lord Drive, Suite 2400, Baltimore, 21224m, MD, USA.
Matthew R LammiJohns Hopkins University Division of Pulmonary Critical Care Medicine, Baltimore, MD, USA.
Stephen C MathaiJohns Hopkins University Division of Pulmonary Critical Care Medicine, Baltimore, MD, USA.
Luna GarganiDepartment of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
Monica MukherjeeJohns Hopkins University Division of Cardiology, 301 Mason Lord Drive, Suite 2400, Baltimore, 21224m, MD, USA. mmukher2@jhu.edu.

Funding

Early Detection of Right Ventricular Dysfunction and Emerging Pulmonary Hypertension in Systemic SclerosisR01HL162851 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Monica Mukherjee · 2023 to 2026
$2.5M
Congressionally Directed Medical Research Programs PR191839Congressionally Directed Medical Research Programs PR231648NHLBI NIH HHS R01HL162851
6 · The paper itself

Abstract

purpose of reviewThe goal of this review is to examine the evolving role of exercise stress echocardiography (ESE) in the diagnosis and management of pulmonary vascular diseases (PVD), particularly pulmonary hypertension (PH). We sought to explore how ESE can assess dynamic cardiopulmonary interactions, distinguish between PH subtypes, evaluate right ventricular (RV) contractile function and reserve, and provide a noninvasive alternative for early detection, risk stratification, and clinical decision-making in patients with unexplained dyspnea and PVD. RECENT

findingsAlthough right heart catheterization (RHC) remains the diagnostic gold standard, ESE has emerged as a promising noninvasive tool to assess dynamic changes in ventricular function, interventricular interactions, cardiopulmonary hemodynamics, and systemic circulation under stress conditions. Beyond traditional ischemic evaluation, ESE has demonstrated potential for identifying underlying causes of dyspnea in populations with rising cardiopulmonary risk factors such as aging, cardiovascular disease, obesity, COPD, and left heart failure. Recent studies highlight the ability of ESE to differentiate PH subtypes and offer prognostic insights. However, important knowledge gaps remain, particularly regarding standardized protocols and interpretation across different PH groups. Our review affirms that ESE offers a valuable, noninvasive approach for the early identification and risk stratification of PH, complementing or, in selected cases, providing an alternative to invasive hemodynamics. By evaluating dynamic cardiopulmonary interactions and RV reserve, ESE can refine diagnosis, improve clinical management, and potentially guide earlier therapeutic interventions in at-risk patients. Future research should focus on standardizing ESE methodologies, validating noninvasive surrogate measures of hemodynamics, and expanding its role in clinical practice to optimize the care of patients with PVD.

Indexed as

Echocardiography, StressHypertension, PulmonaryCardiac CatheterizationDyspneaHemodynamicsHumansPrognosisRisk AssessmentVentricular Function, RightExercise stress echocardiographyExercise stress testingPulmonary hypertensionRight ventricle

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.